Literature DB >> 8302525

Evaluating visual function in cataract.

D B Elliott1.   

Abstract

This paper reviews recent research on the evaluation of visual function in cataract. Visual impairment in cataract is principally caused by increased intraocular forward light scatter. It is assumed that visual acuity (VA) measurements assess the impact of narrow angle light scatter. This also makes the measurement of high spatial frequency contrast sensitivity (CS) unnecessary. However, VA measurements alone are an inadequate assessment of visual impairment in some patients with cataract. In addition, it is suggested that a measurement of wide-angle light scatter is required. This can be evaluated directly using the van den Berg Straylightmeter, or indirectly using low spatial frequency CS or disability glare (DG) tests. The following are discussed: (1) the relative usefulness of these tests; (2) how they can be incorporated into the decision as to when to extract a cataract; and (3) the importance of considering binocular visual function.

Entities:  

Mesh:

Year:  1993        PMID: 8302525     DOI: 10.1097/00006324-199311000-00006

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  20 in total

1.  Effects of yellow filters on visual acuity, contrast sensitivity and reading under conditions of forward light scatter.

Authors:  Frank Eperjesi; Lillian Evangelica Agelis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

2.  Predictions of postoperative visual outcome in subjects with cataract: a preoperative and postoperative study.

Authors:  William A Douthwaite; Marta Vianya-Estopà; David B Elliott
Journal:  Br J Ophthalmol       Date:  2006-11-23       Impact factor: 4.638

3.  Relationship between foveal cone structure and clinical measures of visual function in patients with inherited retinal degenerations.

Authors:  Kavitha Ratnam; Joseph Carroll; Travis C Porco; Jacque L Duncan; Austin Roorda
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-28       Impact factor: 4.799

4.  SPARCS and Pelli-Robson contrast sensitivity testing in normal controls and patients with cataract.

Authors:  L Gupta; V Cvintal; R Delvadia; Y Sun; E Erdem; C Zangalli; L Lu; S S Wizov; J Richman; E Spaeth; G L Spaeth
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

5.  Psychophysical impact and optical and morphological characteristics of symptomatic non-advanced cataract.

Authors:  S Charalampidou; J Nolan; J Loughman; J Stack; G Higgins; L Cassidy; S Beatty
Journal:  Eye (Lond)       Date:  2011-06-10       Impact factor: 3.775

6.  Use of diffusing filters for artificially reducing visual acuity when testing equipment and procedures.

Authors:  Sven P Heinrich; Isabell Strübin
Journal:  Doc Ophthalmol       Date:  2019-09-05       Impact factor: 2.379

7.  Effect of a cataract simulation on clinical and real world vision.

Authors:  D B Elliott; M A Bullimore; A E Patla; D Whitaker
Journal:  Br J Ophthalmol       Date:  1996-09       Impact factor: 4.638

8.  Refractive error changes in cortical, nuclear, and posterior subcapsular cataracts.

Authors:  K Pesudovs; D B Elliott
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

9.  Refractive changes in nuclear, cortical and posterior subcapsular cataracts. effect of the type and grade.

Authors:  Ma Amparo Díez Ajenjo; Ma Carmen García Domene; Cristina Peris Martínez
Journal:  J Optom       Date:  2014-09-02

10.  Visual contrast sensitivity in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints.

Authors:  Shannon L Risacher; Darrell Wudunn; Susan M Pepin; Tamiko R MaGee; Brenna C McDonald; Laura A Flashman; Heather A Wishart; Heather S Pixley; Laura A Rabin; Nadia Paré; Jessica J Englert; Eben Schwartz; Joshua R Curtain; John D West; Darren P O'Neill; Robert B Santulli; Richard W Newman; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2012-10-18       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.